Source:http://linkedlifedata.com/resource/pubmed/id/10998313
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-10-12
|
pubmed:abstractText |
T cell apoptosis represents a common mechanism of T cell depletion in HIV-1-infected individuals reflecting maturational and functional T cell abnormalities either directly or indirectly induced by the virus. In the present study, the effects of highly active antiretroviral therapy (HAART) on the spontaneous apoptosis of distinct T cell subsets were investigated during a 6-month follow-up in a cohort of HIV-1-infected individuals with CD4(+) cell counts between 100 and 500 cells/microliter and plasma HIV-1 RNA levels >/=10, 000 copies/ml. We determined that the rapid and sustained increase of both naive (CD45RA(+)CD62L(+)) and memory (CD45R0(+) and CD45RA(+)/CD62L(-)) CD4(+) and, to as lesser extent, CD8(+) T cells in peripheral blood was associated with a significant decrease of apoptotic CD4(+) and CD8(+) as well as CD3(+)CD4(-)CD8(-) T cells. Among CD4(+) lymphocytes, at enrollment, the highest frequency of apoptotic cells was observed within the memory compartment, as defined by CD45R0 expression. During HAART, however, the frequency of CD4(+)CD45R0(+) apoptotic T cells progressively decreased in association with a significant downregulation of surface activation markers that indicated decreased levels of systemic immune stimulation. These results indicate that effective viral suppression can contribute to progressive normalization of maturational and functional T cell abnormalities responsible for the high levels of T cell apoptosis in HIV-1-infected individuals. This, in turn, may contribute to a reduced rate of T cell loss and immune reconstitution during HAART.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1521-6616
|
pubmed:author |
pubmed-author:AiutiFF,
pubmed-author:AlarioCC,
pubmed-author:CunsoloM GMG,
pubmed-author:De CristofaroMM,
pubmed-author:EnsoliFF,
pubmed-author:FiorelliVV,
pubmed-author:GiovannettiAA,
pubmed-author:MazzettaFF,
pubmed-author:MolliconeBB,
pubmed-author:NoviAA,
pubmed-author:PinterEE,
pubmed-author:Santini MuratoriDD
|
pubmed:copyrightInfo |
Copyright 2000 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
9-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10998313-Adult,
pubmed-meshheading:10998313-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:10998313-Apoptosis,
pubmed-meshheading:10998313-Cohort Studies,
pubmed-meshheading:10998313-Female,
pubmed-meshheading:10998313-Flow Cytometry,
pubmed-meshheading:10998313-Humans,
pubmed-meshheading:10998313-In Situ Nick-End Labeling,
pubmed-meshheading:10998313-Male,
pubmed-meshheading:10998313-Middle Aged,
pubmed-meshheading:10998313-Phenotype,
pubmed-meshheading:10998313-Prospective Studies,
pubmed-meshheading:10998313-T-Lymphocyte Subsets,
pubmed-meshheading:10998313-T-Lymphocytes,
pubmed-meshheading:10998313-Viral Load
|
pubmed:year |
2000
|
pubmed:articleTitle |
Decreased T cell apoptosis and T cell recovery during highly active antiretroviral therapy (HAART).
|
pubmed:affiliation |
Department of Allergy and Clinical Immunology, University of Rome "La Sapienza,", Rome, 00161, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|